Loading...
Entry LevelFull-time
Salary Range
$17,340 - $23,460 /year
This salary is estimated based on similar roles. The actual salary may vary.
Grow your career in an international Finance team that values diversity, expertise and development. Working with us means joining a team that spans across borders, providing access to a wide range of finance functions, while offering opportunities for professional growth and continuous learning.
The Financial Analyst Procure to Pay (βPTPβ) is responsible to provide effective, efficient and accurate financial and administrative support for PTP related processes. Youβll maintain a high level of internal customer satisfaction through quality service and support. Youβll be one of the focal points for local purchase initiators and shared service centers on PTP.
Your tasks contribute to AbbVieβs success and the health of the patients who are at the heart of our work.β―That is where you join us and where you can help us realize our ambitions. Responsibilities include but are not limited to: 
β’ Be one of the local contact persons for all PTP related activities
β’ Responsible for the internal flow of financial documents (invoices / reminders / other)
β’ Create new vendors
β’ Responsible for the invoice management of incidents, communication with the BPO, vendors and users initiating the request
β’ Manage blocked invoices report: research and resolve issues for invoices listed on the Invoice On Hold, Parked, Aging and AP Trial Balance reports
β’ Record KPI for timely processing of invoices locally
β’ Investigate improvement opportunities and risks within the P2P process
β’ Be part of the βone-stop-shopβ approach for local stakeholder for SAP/Foundation global teams for PTP
β’ Perform the activities in compliance with all internal AbbVie procedures and Policies
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
